经颅直流电刺激治疗抑郁的个体患者数据荟萃分析
该个体患者数据荟萃分析纳入18项随机对照试验共1246例急性抑郁发作患者,比较活性与假经颅直流电刺激(tDCS)。活性tDCS对抑郁改善有统计学显著的小效应(Hedges' d=0.24,95%CI 0.11-0.35),应答率优势比为1.33(95%CI 1.04-1.72),但缓解率与脱落率组间无显著差异,仅样本量显著调节临床改善。
要点
- 活性tDCS对抑郁改善有小而显著的效应(d=0.24),应答率OR=1.33。
- 缓解率(OR=1.30,95%CI 0.98-1.74)与脱落率组间无显著差异。
- 仅样本量显著调节临床改善,较大试验的组间差异较小。
核心结论
- 在此个体患者数据集中,tDCS对抑郁显示出适度疗效,未来研究需阐明其机制并考虑非特异性安慰剂效应。
研究设计与样本
- 个体患者数据荟萃分析,检索PubMed、Embase、Web of Science和Cochrane Library截至2025年2月1日的随机对照试验。
- 纳入18个提供个体患者数据的数据集,共1246例急性抑郁发作患者(活性tDCS 651例,假tDCS 595例;平均年龄43.2岁,女性63.4%)。
- 90%的研究偏倚风险为低;异质性用I²统计量量化,发表偏倚用Egger检验评估。
主要发现
- 活性tDCS对抑郁改善有统计学显著的小效应(Hedges' d=0.24,95%CI 0.11-0.35),异质性低至中等。
- 活性tDCS对应答率有显著优势(OR=1.33,95%CI 1.04-1.72)。
- 缓解率组间无显著差异(OR=1.30,95%CI 0.98-1.74)。
- 脱落率活性组12.7%、假组11.3%,组间无显著差异。
- 仅样本量显著调节临床改善,较大试验显示较小的组间差异。
关键数值与推荐
- 主要结局为抑郁症状连续测量的Hedges' g、应答率与缓解率的比值比,以及个体/方法学调节因素分析。
- 可接受性通过脱落率评估;发表偏倚与偏倚风险分别用Egger检验和Cochrane偏倚风险工具评估。
临床怎么用
- 对于急性抑郁发作患者,tDCS可作为具有小效应量的辅助治疗选择,应答率优于假刺激但缓解率优势不显著。
- 临床决策时应考虑tDCS的效应量较小且可能受非特异性安慰剂效应影响。
局限性
- 29项符合条件随机对照试验中仅18项提供个体患者数据,可能存在选择偏倚。
- 仅样本量显著调节临床改善,其他个体或方法学调节因素未发现显著影响。
- 未来研究需阐明tDCS机制并考虑非特异性安慰剂效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcranial direct current stimulation (tDCS) shows promise for treating depression, but heterogeneous findings from randomised controlled trials (RCTs) - likely due to patient characteristics and methodological differences - limit clear conclusions about its efficacy. AIMS: This individual patient data meta-analysis (IPD-MA) aims to evaluate the efficacy of tDCS for depression and explore moderators of clinical depression improvement. METHOD: Databases (PubMed, Embase, Web of Science, Cochrane Library) were searched up to 1 February 2025 for RCTs comparing active versus sham tDCS in acute depressive episodes. The outcomes were Hedges' g for continuous measures of depressive symptoms, odds ratio for response and remission rates and analyses of individual/methodological moderators of clinical improvement. Acceptability was assessed via dropout rates. Heterogeneity was quantified using the I² statistic. Publication and risk of bias were evaluated with Egger's test and Cochrane Risk of Bias Tool, respectively. RESULTS: Of 29 eligible RCTs, 18 data-sets provided IPD, totalling 1246 included in the IPD-MA (651 active, 595 sham; mean age 43.2, 63.4% female). Most studies (90%) had low risk of bias. Active tDCS showed small but statistically significant effects on depression improvement (Hedges' d = 0.24, 95% CI = 0.11-0.35) and response rates (odds ratio 1.33, 95% CI = 1.04-1.72), with low-to-moderate heterogeneity. No significant difference in remission rates (odds ratio 1.30, 95% CI = 0.98-1.74) and dropout rates (12.7% active, 11.3% sham) were observed between groups. Only sample size significantly moderated clinical improvement, with larger trials showing smaller between-group differences. CONCLUSIONS: In this IPD data-set, tDCS showed modest efficacy for depression. Future research should clarify its mechanisms, considering non-specific placebo effects.
引用
- Razza LB, Luethi MS, Moffa A, et al. Efficacy of transcranial direct current stimulation for depression: individual patient data meta-analysis. Br J Psychiatry. 2026. PMID: 41498282. doi:10.1192/bjp.2025.10511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。